{"id":862742,"date":"2023-02-10T06:00:59","date_gmt":"2023-02-10T05:00:59","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/"},"modified":"2023-02-10T06:00:59","modified_gmt":"2023-02-10T05:00:59","slug":"vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/","title":{"rendered":"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP)"},"content":{"rendered":"Vaxxas\u2019 proprietary HD-MAP technology platform has the potential to improve vaccination by creating vaccine products that are easy to use (potentially enabling self-administration) and can be stable at room temperature, reducing the complexities and costs associated with refrigerated distribution.\nThe vaccine being delivered by the Vaxxas HD-MAP in this Phase I clinical trial is a commercially available seasonal flu vaccine (IIV4) targeting four significant strains of the influenza virus. The specific strains of influenza virus targeted in any given seasonal IIV4 are established annually by regulatory health agencies and encompass two strains of influenza A and two strains of influenza B.\nThis Phase I clinical study will include approxima
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Vaxxas\u2019 proprietary HD-MAP technology platform has the potential to improve vaccination by creating vaccine products that are easy to use (potentially enabling self-administration) and can be stable at room temperature, reducing the complexities and costs associated with refrigerated distribution. The vaccine being delivered by the Vaxxas HD-MAP in this Phase I clinical trial is a […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-862742","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nVaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP) - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP) - BeBeez\" \/>\n<meta property=\"og:description\" content=\"Vaxxas\u2019 proprietary HD-MAP technology platform has the potential to improve vaccination by creating vaccine products that are easy to use (potentially enabling self-administration) and can be stable at room temperature, reducing the complexities and costs associated with refrigerated distribution. The vaccine being delivered by the Vaxxas HD-MAP in this Phase I clinical trial is a […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-10T05:00:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP)\",\"datePublished\":\"2023-02-10T05:00:59+00:00\",\"dateModified\":\"2023-02-10T05:00:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/\"},\"wordCount\":1118,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/\",\"name\":\"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP) - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2023-02-10T05:00:59+00:00\",\"dateModified\":\"2023-02-10T05:00:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP) - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/","og_locale":"en_US","og_type":"article","og_title":"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP) - BeBeez","og_description":"Vaxxas\u2019 proprietary HD-MAP technology platform has the potential to improve vaccination by creating vaccine products that are easy to use (potentially enabling self-administration) and can be stable at room temperature, reducing the complexities and costs associated with refrigerated distribution. The vaccine being delivered by the Vaxxas HD-MAP in this Phase I clinical trial is a […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/","og_site_name":"BeBeez","article_published_time":"2023-02-10T05:00:59+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/"},"author":{"name":"","@id":""},"headline":"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP)","datePublished":"2023-02-10T05:00:59+00:00","dateModified":"2023-02-10T05:00:59+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/"},"wordCount":1118,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/","name":"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP) - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2023-02-10T05:00:59+00:00","dateModified":"2023-02-10T05:00:59+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-initiates-phase-i-clinical-study-of-first-needle-free-inactivated-seasonal-influenza-vaccine-quadrivalent-iiv4-delivered-using-high-density-microarray-patch-hd-map\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP)"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/862742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=862742"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/862742\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=862742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=862742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=862742"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=862742"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=862742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}